[ Price : $8.95]
Four stakeholders recommend ways FDA can improve a draft guidance on leveraging prior knowledge in developing some human gene ther...[ Price : $8.95]
FDA warns Fresenius Medical Care North America about CGMP violations at its Ogden, UT, drug manufacturing facility.[ Price : $8.95]
FDA posts two guidance documents on dental composite resins and curing lights.[ Price : $8.95]
FDA warns Indias Reliance Life Sciences about significant CGMP violations in its production of finished drugs.[ Price : $8.95]
FDA warns Jabil Inc. about significant CGMP violations at its Pharmaceutics International unit in Cockeysville, MD.[ Price : $8.95]
Novartis and Bristol Myers Squibb confirm to BioSpace that they are suspending some CAR T candidate trials to evaluate adverse eve...[ Price : $8.95]
FDA adds a new frequently asked questions section to its Web page on PFAS (per- and polyfluoroalkyl substances) in medical devices...[ Price : $8.95]
FDA releases a draft guidance entitled Pharmacokinetics in Patients with Impaired Hepatic Function: Study Design, Data Analysis, a...